How did Dole (NYSE:DOLE) perform in Q1 2026?

Dole reported first-quarter 2026 revenue of $X (exact figure not provided), marking an 11.6% year-over-year increase. The growth was driven by strong performance in the Diversified Fresh Produce segments across the Americas, Rest of World (ROW), and EMEA, offsetting a softer Fresh Fruit division. Net income was $37.7 million, or $0.33 per diluted share, while adjusted EBITDA reached $100.3 million.

What drove Dole’s revenue growth in Q1 2026?

Revenue growth was powered by global health and wellness trends, as well as the widespread adoption of GLP-1 drugs, which boosted demand for fresh fruits and vegetables. Strong performance in Dole’s Diversified Fresh Produce segments across multiple regions was the primary driver.

How did Dole perform in terms of profitability?

Dole reported net income of $37.7 million, or $0.33 per diluted share, for Q1 2026. Adjusted net income was $31.2 million, also translating to an adjusted diluted EPS of $0.33. Adjusted EBITDA came in at $100.3 million, in line with the company’s internal projections.

What segments contributed most to Dole’s growth?

The Diversified Fresh Produce segments in the Americas, ROW, and EMEA regions contributed most to growth, reflecting strong international demand. These gains offset weaker performance in the Fresh Fruit division, helping maintain overall revenue momentum.

How is Dole managing its logistics and portfolio?

Dole received regulatory approval for the sale of its port terminal in Ecuador, a move that is expected to finalize before the end of Q2 2026. This transaction supports the company’s portfolio optimization strategy by streamlining its logistics footprint and providing additional liquidity.

Dole revenue surges 11.6% as GLP-1 trends bolster fresh produce demand

Written by Mahathir BayenaPublished May. 11 2026Last Updated May. 11 2026

Dole (NYSE:DOLE) posted an 11.6% increase in revenue for the first quarter of 2026, a result the company attributed to a "solid start" powered by global health and wellness movements.

The Dublin-based produce giant reported that evolving dietary preferences and the widespread adoption of GLP-1 drugs are creating tailwinds for the fresh fruit and vegetable sectors.

The company's Diversified Fresh Produce segments in the Americas, Rest of World (ROW), and EMEA regions showed strong momentum, which helped offset a softer performance in the Fresh Fruit division.

For the three months ended March 31, 2026, Dole reported net income of $37.7 million, or $0.33 per diluted share.

Adjusted EBITDA came in at $100.3 million, meeting the company's internal projections.

Adjusted net income was reported at $31.2 million, also resulting in an adjusted diluted EPS of $0.33.

Following the close of the quarter, Dole reached a milestone in its portfolio optimization strategy by receiving regulatory approval for the sale of its port terminal in Ecuador.

The company expects to finalize the transaction before the end of the second quarter, providing additional liquidity and streamlining its logistics footprint.